Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hosam El Sayed

Vascular Surgery Virginia Beach, VA Medical Doctor

NPI 1063598977 CMS profile 1133983

397 Little Neck Rd Ste 120, Virginia Beach, VA 23452

Open in the dashboard

General payments

$59,783

328 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$17,197 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Hosam El Sayed of Virginia Beach, VA is reported in the CMS Open Payments database as having received $59,783 across 328 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $17,197 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,461 53
2024 General $5,205 64
2023 General $4,878 57
2022 General $14,412 44
2021 General $18,633 53
2020 General $9,000 35
2019 General $3,194 22

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hosam El Sayed
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Hosam El Sayed were reported at $4,461. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Hosam El Sayed Vascular Surgery median Middle half National median
2019 $3,194 $796 $226–$2,363 $163
2020 $9,000 $348 $118–$1,110 $114
2021 $18,633 $471 $158–$1,421 $132
2022 $14,412 $725 $222–$2,183 $149
2023 $4,878 $836 $257–$2,440 $160
2024 $5,205 $909 $252–$2,619 $164
2025 $4,461 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $36,453 144 payments
  2. W. L. Gore & Associates, Inc. $4,530 39 payments
  3. Covidien LP $4,500 2 payments
  4. Medtronic Vascular, Inc. $2,635 21 payments
  5. Cook Medical LLC $2,489 21 payments
  6. Penumbra, Inc. $1,751 13 payments
  7. Bolton Medical Inc $1,510 19 payments
  8. Philips Electronics North America Corporation $937 9 payments
  9. Silk Road Medical, Inc. $886 6 payments
  10. Endologix, Inc. $879 11 payments
  11. Other $3,215 43 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $21,710 266 payments
  2. Consulting Fee $17,438 4 payments
  3. Travel and Lodging $14,467 54 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,880 3 payments
  5. Grant $1,289 1 payment
Products named General payments · program years 2019–2025
  1. Argyle Dialysis Catheters $23,177 9 payments
  2. ENDURANT IIS $7,049 82 payments
  3. Argyle Dialysis Catheters $4,500 2 payments
  4. Valiant Captivia Aortic Stent Grafts $1,483 7 payments
  5. Indigo System $1,474 9 payments
  6. Valiant Captivia Aortic Stent Grafts $1,457 13 payments
  7. TREO ABDOMINAL STENT-GRAFT SYSTEM $982 14 payments
  8. Endurant $948 12 payments
  9. Product in Development $898 7 payments
  10. TAG Thoracic Endoprosthesis $873 2 payments
  11. Other $15,836 180 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

47

Median for Vascular Surgery: 122

Drug cost

$354

Median for Vascular Surgery: $14,135

Branded share of claims

23.4%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cilostazol Generic 36 $297
Clopidogrel Clopidogrel Bisulfate Brand 11 $56

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 123 billing codes

Paid by Medicare

$233,412

Medicare's payments for the services billed

Medicare patients

3,460

Average age 75

Services billed

4,778

1,731 women, 1,729 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 48%
Diabetes 44%
Chronic kidney disease 44%
Heart failure 40%
COPD 30%
Atrial fibrillation 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

328 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record